OxyNorm Dispersa 5 mg Orodispersible Tablets
Authorisation PA1688/006/007 · Mundipharma Pharmaceuticals Limited
- Licence holder
- Mundipharma Pharmaceuticals Limited (all products →)
- Active substance
- OXYCODONE HYDROCHLORIDE
- Clinical trials
- 7 clinical trials →
- Dosage form
- Orodispersible tablet
- Route of administration
- Oral use
- ATC codes
- N02AA, N02AA05
- First authorised
- 16/07/2010
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
OXYCODONE HYDROCHLORIDE: supply and approvals
45 authorised products on the HPRA list contain OXYCODONE HYDROCHLORIDE. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 16 years (since 16 July 2010). The HPRA list marks it as marketed in Ireland.
Other medicines with OXYCODONE HYDROCHLORIDE in Ireland
44 other products on the HPRA list contain OXYCODONE HYDROCHLORIDE, from 7 licence holders; 23 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Dancex SR 10 mg Prolonged-Release Tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Dancex SR 20 mg Prolonged-Release Tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Dancex SR 5 mg Prolonged-Release Tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| OxyContin 10 mg prolonged release tablets | Mundipharma Pharmaceuticals Limited | National authorisation (PA) | Marketed |
| OxyContin 20 mg prolonged release tablets | Mundipharma Pharmaceuticals Limited | National authorisation (PA) | Marketed |
| OxyContin 40 mg prolonged release tablets | Mundipharma Pharmaceuticals Limited | National authorisation (PA) | Marketed |
| OxyContin 5 mg prolonged release tablets | Mundipharma Pharmaceuticals Limited | National authorisation (PA) | Marketed |
| OxyNorm 10 mg hard capsules | Mundipharma Pharmaceuticals Limited | National authorisation (PA) | Marketed |
| OxyNorm 10 mg/ml, solution for injection or infusion | Mundipharma Pharmaceuticals Limited | National authorisation (PA) | Marketed |
| OxyNorm 20 mg hard capsules | Mundipharma Pharmaceuticals Limited | National authorisation (PA) | Marketed |
| OxyNorm 5 mg hard capsules | Mundipharma Pharmaceuticals Limited | National authorisation (PA) | Marketed |
| OxyNorm 50 mg/ml, solution for injection or infusion | Mundipharma Pharmaceuticals Limited | National authorisation (PA) | Marketed |
Other substances in ATC group N02AA
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 10 other active substances share the group N02AA with this product:
Morphine sulfate (10) · Naloxone hydrochloride dihydrate (7) · NALOXONE HYDROCHLORIDE (6) · Hydromorphone hydrochloride (5) · CYCLIZINE TARTRATE (2) · Morphine tartrate (1) · Morphine Tartrate BPC 1959 (1) · Dihydrocodeine tartrate (1) · Dihydrocodeine hydrorhodanide (1) · Dihydrocodeine Hydrogen Tartrate (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Mundipharma Pharmaceuticals Limited holds 47 products on the HPRA list, with 9 different active substances; 45 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.